Covid-19: Oxford to hold a global trial of its vaccine

Oxford University has decided to hold a global trial of its vaccine after doubts were raised over its effectiveness and preparation procedure. However, Oxford has assured that it will continue to produce doses for public consumption and the trial will not affect the production process at mass scale. Meanwhile, the British government has started the process to certify the vaccine developed by Oxford.